D-Mannose
|
Basic information |
| Metabolite name | D-Mannose |
 | HMDB0000169 |
 |
C00936 |
 |
18950 |
| Synonyms | Mannose |
| No. of studies | 11 |
|
Basic information |
| Metabolite name | D-Mannose |
| HMDB0000169 |
|
C00936 |
|
18950 |
| Synonyms | Mannose |
| No. of studies | 11 |
|
Relationship between D-Mannose and depression (count: 11) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M040 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M087 | Type2 | ketamine group 2-h vs. baseline | Plasma | Human | Up |
| Study M1072 | Type1 | CUMS group vs. control group | Plasma | Cynomolgus monkey | Down |
| Study M113 | Type1 | CUMS group vs. control group | Serum | Wistar rat | Down |
| Study M480 | Type2 | CGA-treated group vs. sleep deprivation group | Urine | Wistar rat | Down |
| Study M749 | Type1 | CUMS group vs. control group | Plasma | Cynomolgus monkey | Down |
| Study M894 | Type1 | electromagnetic field exposure group vs. control group | Serum | C57BL/6J mouse | Up |
| Study M894 | Type2 | electromagnetic field exposure + heat acclimation group vs. electromagnetic field exposure group | Serum | C57BL/6J mouse | Down |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M943 | Type2 | CUMS + middle dose of Acanthopanax senticosus Harms group vs. CUMS group | Liver | ICR mouse | Up |
| Study M943 | Type2 | CUMS + fluoxetine group vs. CUMS group | Liver | ICR mouse | Up |
| Study M943 | Type2 | CUMS + low dose of Acanthopanax senticosus Harms group vs. CUMS group | Liver | ICR mouse | Up |
| Study M943 | Type2 | CUMS + high dose of Acanthopanax senticosus Harms group vs. CUMS group | Liver | ICR mouse | Up |
| Study M956 | Type2 | CUMS + whey protein-based group vs. CUMS group | Faece | C57BL/6J mouse | Up |
| Study M981 | Type1 | Abeta oligomer group vs. control group | Serum | ICR mouse | Up |
| Study M981 | Type2 | Abeta oligomer + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Down |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running group vs. Abeta oligomer group | Serum | ICR mouse | Down |